Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-09-28 6:4:34 am | Earn Double-Digit Income With Options (October 2023) | SeekingAlpha |
| 2023-09-26 1:29:0 pm | The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out | The Wall Street Journal |
| 2023-09-26 12:33:26 pm | 15 Best Dividend Aristocrat Stocks To Buy Now | Insider Monkey |
| 2023-09-26 7:56:0 am | AbbVie's (ABBV) Epcoritamab Gets Approval in Europe for DLBCL | Zacks |
| 2023-09-26 6:0:12 am | AbbVie Inc.'s (NYSE:ABBV) Intrinsic Value Is Potentially 57% Above Its Share Price | Simply Wall St. |
| 2023-09-25 2:45:19 pm | AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know | Zacks |
| 2023-09-25 4:45:0 am | AbbVie Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or Refractory Diffuse Large B-cell Lymphoma | PR Newswire |
| 2023-09-22 2:3:42 pm | UPDATE 1-AbbVie terminates deal with I-Mab to develop cancer drug | Reuters |
| 2023-09-22 1:28:14 pm | AbbVie terminates deal with I-Mab to develop cancer drug | Reuters |
Please consider a small donation if you think this website provides you with relevant information